Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs reduced the risk of early-stage breast ...
Dec 6, 2017
0
1
(Medical Xpress)—The ability to directly observe the body is an invaluable tool in the arsenal of any medical professional. In fact, physical inspection comes only second to discussion of symptoms and medical history in ...
Oct 15, 2013
0
0
Loss of TLK1 and TLK2 results in extensive DNA damage during DNA replication and in cancer cell death. Depletion of TLK1/2 enhances the effectiveness of some chemotherapeutic agents currently being tested in clinical trials
Aug 9, 2018
0
0
Exposure to Agent Orange is associated with a small but significantly increased risk of bladder cancer among male Vietnam veterans, according to a study published online June 27 in JAMA Network Open.
Jun 29, 2023
0
2
A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the ...
Dec 2, 2013
0
0
The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major ...
Dec 3, 2012
0
0
In a review of existing research, a team of Australian researchers found that milk proteins, consisting of short sequences called peptides, are potential candidates for the development of anticancer agents and can be generated ...
Feb 19, 2015
0
4
African-American women who survive breast cancer are more likely to develop heart failure than other women who have beaten the disease, according to research being presented at the American College of Cardiology's 62nd Annual ...
Mar 7, 2013
0
0
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential ...
Dec 4, 2012
0
0
A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. Based on these promising results ...
Jun 10, 2019
0
1
